CMED
From China Stock Market
From Reuters: China Medical Technologies, Inc. is a China-based medical device company that develops, manufactures and markets in-vitro diagnostics (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, magnetic antibody immunoassay technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood, urine or other body fluids, and system using high intensity focused ultrasound for the treatment of solid cancers and benign tumors. The Company’s enhanced chemiluminescence immunoassay system is a luminescence immunoassay IVD system based on the enhanced chemiluminescence immunoassay technology. Luminescence immunoassay IVD systems are advanced types of IVD systems used in the United States and Western Europe, but are relatively new in China.
The company expect to launch its SPR system in April of 2009, and it is now marketing its newest tests, the Prenatal and Cervical Cancer FISH probes and the Breast Cancer HER-2 FISH probe.
Contents |
How To Invest
China Medical Technologies, Inc. is traded on the NYSE under stock symbol WX.
Competitors
Pharmaceutical Product Development, Inc. (PPD) in the United States offers similar services to the pharmaceutical and biotechnology customers.
Key Development
- In December 2008, China Medical Technologies, Inc. sold its High Intensity Focused Ultrasound tumor therapy system business to Chengxuan International Ltd.
- China Medical Technologies, Inc. bought Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders.
Other Stocks
